Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FRUQUINTINIB vs FULVESTRANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FRUQUINTINIB vs FULVESTRANT: Safety Overview

Metric FRUQUINTINIB FULVESTRANT
Total FAERS Reports 2,565 17,675
Deaths Reported 874 3,087
Death Rate 34.1% 17.5%
Hospitalizations 753 4,103
Average Patient Age 63.9 yrs 63.0 yrs
% Female Patients 44.4% 99.0%
FDA Approval Date Nov 8, 2023 Apr 25, 2002
Manufacturer Takeda Pharmaceuticals America, Inc. BluePoint Laboratories
Route ORAL INTRAMUSCULAR
Marketing Status Prescription Prescription